<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<meta property="og:title" content="Cross-border spread of AMR |    97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES" />
<meta property="og:type" content="book" />





<meta name="author" content="Russell E. Lewis, Associate Professor, Infectious Diseases, University of Bologna" />


<script type="text/x-mathjax-config">
MathJax.Hub.Config({
  TeX: { equationNumbers: { autoNumber: "AMS" } }
});
</script>
  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

<meta name="description" content="Cross-border spread of AMR |    97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES">

<title>Cross-border spread of AMR |    97039 - GLOBAL HEALTH, ANTIMICROBIAL DRUGS AND VACCINES</title>

<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="libs/bootstrap-3.3.5/css/bootstrap.min.css" rel="stylesheet" />
<script src="libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="libs/navigation-1.1/tabsets.js"></script>




<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="toc.css" type="text/css" />

<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
/* show arrow before summary tag as in bootstrap
TODO: remove if boostrap in updated in html_document (rmarkdown#1485) */
details > summary {
  display: list-item;
  cursor: pointer;
}
</style>
</head>

<body>

<div class="container-fluid main-container">


<div class="row">
<div class="col-sm-12">
<div id="TOC">
<ul>
<li><a href="a-brief-history-of-antimicrobial-resistance-amr.html#a-brief-history-of-antimicrobial-resistance-amr">A brief history of antimicrobial resistance (AMR)</a></li>
<li><a href="global-response-to-antimicrobial-resistance.html#global-response-to-antimicrobial-resistance">Global response to antimicrobial resistance</a></li>
<li><a href="what-are-the-drivers-of-antimicrobial-resistance.html#what-are-the-drivers-of-antimicrobial-resistance">What are the drivers of antimicrobial resistance?</a></li>
<li><a href="amr-in-low-middle-income-countries-lmics.html#amr-in-low-middle-income-countries-lmics">AMR in Low-Middle Income Countries (LMICs)</a>
<ul>
<li><a href="amr-in-low-middle-income-countries-lmics.html#how-can-the-effectiveness-of-antimicrobials-be-preserved">How can the effectiveness of antimicrobials be preserved?</a></li>
<li><a href="amr-in-low-middle-income-countries-lmics.html#case-study-a-successful-national-antibiotic-stewardship-program-in-a-lmic">Case study: A successful national antibiotic stewardship program in a LMIC</a></li>
</ul></li>
<li><a href="amr-situation-in-italy.html#amr-situation-in-italy">AMR situation in Italy</a></li>
<li><a href="the-global-future-of-amr.html#the-global-future-of-amr">The global future of AMR</a></li>
<li><a href="one-health-perspective-of-amr.html#one-health-perspective-of-amr">One-Health Perspective of AMR</a>
<ul>
<li><a href="one-health-perspective-of-amr.html#antibiotic-use-in-animal-food-production">Antibiotic use in animal food production</a></li>
<li><a href="one-health-perspective-of-amr.html#the-impact-of-animal-antibiotic-use-on-human-amr">The impact of animal antibiotic use on human AMR</a></li>
<li><a href="one-health-perspective-of-amr.html#antimicrobial-resistance-in-animals-in-lmics">Antimicrobial resistance in animals in LMICs</a></li>
<li><a href="one-health-perspective-of-amr.html#environmental-concerns">Environmental concerns</a></li>
</ul></li>
<li><a href="cross-border-spread-of-amr.html#cross-border-spread-of-amr">Cross-border spread of AMR</a></li>
<li><a href="summary.html#summary">Summary</a></li>
<li><a href="lecture-slides.html#lecture-slides">Lecture Slides</a></li>
<li><a href="references.html#references">References</a></li>
</ul>
</div>
</div>
</div>
<div class="row">
<div class="col-sm-12">
<div id="cross-border-spread-of-amr" class="section level2 unnumbered">
<h2>Cross-border spread of AMR</h2>
<figure>
<center>
<p><img src="images/worldairlineroute2014.png" width="800" /></p>
<figcaption>
<p><strong>Figure 16. World airline travel routes in 2014.</strong> Photo credit Jpatokal/Wikimedia (CC BY-SA 2.5)</p>
</figcaption>
</center>
</figure>
<p>The COVID-19 pandemic has exposed the limitations of global collaboration and response within existing global health frameworks, pointing to a clear need for more rules-based global governance to be able to effectively prevent, prepare and respond to health emergencies in a more just equitable way. However, valuable lessons from COVID-19 pandemic could enhance actions against AMR. (Table 1.2). Clearly, actions taken by one country have had substantial consequences for others. governments should significantly bolster global and national capacity to prevent and respond to global cross-border health threats more broadly.</p>
<figcaption>
<p>Table 1.2 Global successes and shortcomings in the multilateral response to the COVID-19 pandemic. Table is from Jit et al 2021.<span class="citation"><sup>25</sup></span></p>
</figcaption>
</center>
</figure>
<table>
<colgroup>
<col width="16%" />
<col width="45%" />
<col width="37%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Domain</th>
<th align="left">Successes</th>
<th align="left">Shortcomings</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left"><strong>Research collaboration and information sharing</strong></td>
<td align="left"><ul>
<li><p>Sharing of information by researchers</p></li>
<li><p>International research collaborations</p></li>
<li><p>Public data repositories</p></li>
</ul></td>
<td align="left"><ul>
<li><p>Many regions and countries slow to learn policy lessons from elsewhere</p></li>
<li><p>Lack of systemic global research governance</p></li>
<li><p>Duplication of research studies</p></li>
</ul></td>
</tr>
<tr class="even">
<td align="left"><strong>Vaccine discovery and development</strong></td>
<td align="left"><ul>
<li><p>Multinational initiatives to fund efforts such as the Coronavirus Global Response and the Coalition for Epidemic Preparedness Innovations</p></li>
<li><p>Approval of vaccines and adjuvants</p></li>
<li><p>Establishing the principle of equitable vaccine distribution through the COVAX Facility (despite failures in implementation)</p></li>
</ul></td>
<td align="left"><ul>
<li><p>Most funding from national efforts</p></li>
<li><p>Most vaccine doses secured by rich countries through bilateral deals</p></li>
<li><p>Trade barriers around vaccines and raw materials</p></li>
</ul></td>
</tr>
<tr class="odd">
<td align="left"><strong>Travel policies</strong></td>
<td align="left"><ul>
<li>Travel restrictions delayed spread from China in early 2020</li>
</ul></td>
<td align="left"><ul>
<li><p>Dissonant COVID-19 response policies between highly connected nations</p></li>
<li><p>Restrictions on travel to countries of high COVID-19 incidence contribute little to control in these countries</p></li>
</ul></td>
</tr>
</tbody>
</table>
<p><strong>The actions of the EU during the pandemic illustrate the tension between short-term nationalistic incentives and long-term imperatives for cooperation towards achieving global public goods such as reducing antimicrobial resistance.</strong> The EU has struggled to balance preferences of individual member-states (and those of their political leaderships), with the collective interests of all member-states. Such tensions are especially challenging when health care and health policy issues are involved, given how these have hitherto remained largely the responsibility of the member-states. In a pandemic, this can lead to inertia and political indecisiveness at the EU level, with member-states filling the gap with potentially contradictory or competing decisions.</p>
<p>Looking ahead, it is likely that there will be several changes to the global health architecture, possibly including a new pandemic treaty and additional international collaborative mechanisms to promote preparedness and coordinate responses. In the following sections, we explore what those developments might look like in three key areas.</p>
</div>
<p style="text-align: center;">
<a href="one-health-perspective-of-amr.html"><button class="btn btn-default">Previous</button></a>
<a href="summary.html"><button class="btn btn-default">Next</button></a>
</p>
</div>
</div>


</div>

<script>

// add bootstrap table styles to pandoc tables
$(document).ready(function () {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
});

</script>

</body>
</html>
